Publications High Cost Therapy Profile: October 2024 Eladocagene Exuparvovec October 15, 2024 Neurology Eladocagene Exuparvovec Intrapuraminal PTC Therapeutics, Inc. Proposed indications...

Tap into predictive analytics Our advanced analytics platform helps boost your clinical impact and drive down costs by delivering descriptive, diagnostic, predictive and prescriptive analytics....

Get support from the specialists in specialty We provide end-to-end support for patients taking specialty meds, helping them navigate the care journey. Breadcrumb Home Pharmacy Specialty Pharmacy...

Eyebrow High-Cost Therapy Profile: August 2024 Detailed information about intravenous (IV) linvoseltamab August 15, 2024 High Cost Therapy Profile Oncology Linvoseltamab, intravenous (IV) Regeneron...

These new solutions reflect Prime's distinctive conflict-free approach to the prescription drug supply chain model.

Comprehensive PDL services With 40+ years of Medicaid pharmacy experience supporting over half the nation’s programs, we help states manage high drug costs and ensure members get the meds they...

Experience a different kind of PBM We’re your trusted, transparent partner that’s reimagining pharmacy solutions to deliver value back to those we serve and transforming our industry for the...

Upgrade provides streamlined patient support and enhanced digital engagement for data-driven, holistic care

Event will feature David Lassen, chief clinical officer

Annual conference features presentations, panels, discussions and networking

Prime Careers Spotlight: November 2024 Check out our latest job openings. Together, we can help make health care better by helping clients and members navigate pharmacy benefits. Investment...

Breadcrumb Home Newsroom Custom Content Publications High-Cost Therapy Profile: September 2024 PUBLIcATIonS High-Cost Therapy Profile: September 2024 Detailed information about Intravenous (IV)...

Dinesh Kandanchatha joined the organization July 1.

PUBLICATIONS FDA Decisions Expected: April 2025 Your monthly synopsis of new drugs expected to hit the market March 14, 2025 Drug pipeline for April 2025 At Prime Therapeutics (Prime), we have...

Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

publications Drug Approvals: November 2024 Critical updates in an ever-changing environment This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a...

Start a medication therapy management internship Get hands-on pharmacy experience and develop leadership, strategic-planning and patient care skills with our medication therapy management and...

Expert Clinical Network Insights Metastatic Synovial Sarcoma October 21, 2024 Medication insights: afamitresgene autoleucel (Tecelra) The U.S. Food and Drug Administration (FDA) approved...

Managed Markets Insight & Technology (MMIT)

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey